Found: 32
Select item for more details and to access through your institution.
Hydroxychloroquine prescription trends and predictors for excess dosing per recent ophthalmology guidelines.
- Published in:
- Arthritis Research & Therapy, 2018, v. 20, n. 1, p. N.PAG, doi. 10.1186/s13075-018-1634-8
- By:
- Publication type:
- Article
Nitrated nucleosome levels and neuropsychiatric events in systemic lupus erythematosus; a multi-center retrospective case-control study.
- Published in:
- Arthritis Research & Therapy, 2017, v. 19, p. 1, doi. 10.1186/s13075-017-1495-6
- By:
- Publication type:
- Article
Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays.
- Published in:
- Journal of Clinical Investigation, 2005, v. 115, n. 12, p. 3428, doi. 10.1172/JCI23587
- By:
- Publication type:
- Article
Belimumab or anifrolumab for systemic lupus erythematosus? A risk-benefit assessment.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.980079
- By:
- Publication type:
- Article
The Impact of Vitamin D on Dendritic Cell Function in Patients with Systemic Lupus Erythematosus.
- Published in:
- PLoS ONE, 2010, v. 5, n. 2, p. 1, doi. 10.1371/journal.pone.0009193
- By:
- Publication type:
- Article
Phenotypic Characterization of Autoreactive B Cells- Checkpoints of B Cell Tolerance in Patients with Systemic Lupus Erythematosus.
- Published in:
- PLoS ONE, 2009, v. 4, n. 6, p. 1, doi. 10.1371/journal.pone.0005776
- By:
- Publication type:
- Article
A Provider‐Based Approach to Address Racial Disparities in Lupus Clinical Trial Participation.
- Published in:
- Arthritis Care & Research, 2023, v. 75, n. 7, p. 1434, doi. 10.1002/acr.25054
- By:
- Publication type:
- Article
Evaluating the Construct of Damage in Systemic Lupus Erythematosus.
- Published in:
- Arthritis Care & Research, 2023, v. 75, n. 5, p. 998, doi. 10.1002/acr.24849
- By:
- Publication type:
- Article
Impact of Belimumab on Organ Damage in Systemic Lupus Erythematosus.
- Published in:
- Arthritis Care & Research, 2022, v. 74, n. 11, p. 1822, doi. 10.1002/acr.24901
- By:
- Publication type:
- Article
Comparison of the 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology Systemic Lupus Erythematosus Classification Criteria With Two Sets of Earlier Systemic Lupus Erythematosus Classification Criteria.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Comparison of the Lupus Foundation of America-Rapid Evaluation of Activity in Lupus to More Complex Disease Activity Instruments As Evaluated by Clinical Investigators or Real-World Clinicians.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Neurocognitive impairment in childhood-onset systemic lupus erythematosus: measurement issues in diagnosis.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Decreased live births in women with systemic lupus erythematosus.
- Published in:
- Arthritis Care & Research, 2011, v. 63, n. 7, p. 1068, doi. 10.1002/acr.20466
- By:
- Publication type:
- Article
Smoking Is the Most Significant Modifiable Lung Cancer Risk Factor in Systemic Lupus Erythematosus.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Inhibition of IRF5 hyperactivation protects from lupus onset and severity.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Safety and clinical activity of atacicept in the long-term extension of the phase 2b ADDRESS II study in systemic lupus erythematosus.
- Published in:
- Rheumatology, 2021, v. 60, n. 11, p. 5379, doi. 10.1093/rheumatology/keab115
- By:
- Publication type:
- Article
Attainment of treat-to-target endpoints in SLE patients with high disease activity in the atacicept phase 2b ADDRESS II study.
- Published in:
- Rheumatology, 2020, v. 59, n. 10, p. 2930, doi. 10.1093/rheumatology/keaa029
- By:
- Publication type:
- Article
A double-blind, placebo-controlled, phase II, randomized study of lovastatin therapy in the treatment of mildly active rheumatoid arthritis.
- Published in:
- Rheumatology, 2020, v. 59, n. 7, p. 1505, doi. 10.1093/rheumatology/kez471
- By:
- Publication type:
- Article
Quantitative neuroimaging advances in the measurement of brain injury but not brain function in systemic lupus erythematosus.
- Published in:
- Annals of Neurology, 2008, v. 64, n. 6, p. 600, doi. 10.1002/ana.21563
- By:
- Publication type:
- Article
A pilot study to determine the optimal timing of the Physician Global Assessment (PGA) in patients with systemic lupus erythematosus.
- Published in:
- Immunologic Research, 2015, v. 63, n. 1-3, p. 167, doi. 10.1007/s12026-015-8712-7
- By:
- Publication type:
- Article
Serologic features of cohorts with variable genetic risk for systemic lupus erythematosus.
- Published in:
- Molecular Medicine, 2018, v. 24, n. 1, p. N.PAG, doi. 10.1186/s10020-018-0019-4
- By:
- Publication type:
- Article
Differences in Regional Brain Activation Patterns Assessed by Functional Magnetic Resonance Imaging in Patients with Systemic Lupus Erythematosus Stratified by Disease Duration.
- Published in:
- Molecular Medicine, 2011, v. 17, n. 11/12, p. 1349, doi. 10.2119/molmed.2011.00185
- By:
- Publication type:
- Article
The Fourth Bioelectronic Medicine Summit "Technology Targeting Molecular Mechanisms": current progress, challenges, and charting the future.
- Published in:
- Bioelectronic Medicine, 2021, v. 7, n. 1, p. 1, doi. 10.1186/s42234-021-00068-6
- By:
- Publication type:
- Article
Long‐Term Safety and Efficacy of Belimumab in Patients With Systemic Lupus Erythematosus.
- Published in:
- Arthritis & Rheumatology, 2018, v. 70, n. 6, p. 868, doi. 10.1002/art.40439
- By:
- Publication type:
- Article
Understanding the Antibody Repertoire in Neuropsychiatric Systemic Lupus Erythematosus and Neuromyelitis Optica Spectrum Disorder.
- Published in:
- Arthritis & Rheumatology, 2018, v. 70, n. 2, p. 277, doi. 10.1002/art.40356
- By:
- Publication type:
- Article
Checkpoints for Autoreactive B Cells in the Peripheral Blood of Lupus Patients Assessed by Flow Cytometry.
- Published in:
- Arthritis & Rheumatology, 2016, v. 68, n. 9, p. 2210, doi. 10.1002/art.39710
- By:
- Publication type:
- Article
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Treatment With Sirukumab (CNTO 136) in Patients With Active Lupus Nephritis.
- Published in:
- Arthritis & Rheumatology, 2016, v. 68, n. 9, p. 2174, doi. 10.1002/art.39722
- By:
- Publication type:
- Article
Randomized, Double-Blind, Placebo-Controlled Trial of the Effect of Vitamin D<sub>3</sub> on the Interferon Signature in Patients With Systemic Lupus Erythematosus.
- Published in:
- Arthritis & Rheumatology, 2015, v. 67, n. 7, p. 1848, doi. 10.1002/art.39108
- By:
- Publication type:
- Article
The link between vitamin D deficiency and systemic lupus erythematosus.
- Published in:
- Current Rheumatology Reports, 2008, v. 10, n. 4, p. 273, doi. 10.1007/s11926-008-0044-3
- By:
- Publication type:
- Article
Addition of constitutional symptoms to the SLEDAI-2K improves overall disease activity assessment: A pilot study.
- Published in:
- Lupus, 2024, v. 33, n. 8, p. 840, doi. 10.1177/09612033241249785
- By:
- Publication type:
- Article
Anti-beta 2 glycoprotein I IgA in the SLICC classification criteria dataset.
- Published in:
- Lupus, 2021, v. 30, n. 8, p. 1283, doi. 10.1177/09612033211014248
- By:
- Publication type:
- Article